Get started
NovelStem International Corp.NovelStem International Corp.NovelStem International Corp.

NovelStem International Corp.

No trades
See on Supercharts
Overview
Financials
News Discussions Technicals Seasonals

NSTM fundamentals

Key facts

Market capitalization—
Dividend yield (indicated)—
Price to earnings Ratio (TTM)—
Basic EPS (TTM)—
Founded—
Employees (FY)—
CEO—
Website—
About

NovelStem International Corp. develops novel diagnostic technology that can predict patients resistance to chemotherapy allowing for cancer treatments and the potential to reduce resistance to chemotherapy. The company was founded by Mitchell Rubenstein and Laurie S. Silvers on January 22, 1993 and is headquartered in Boca Raton, FL.

Valuation

Fundamental metrics to determine fair value of the stock

Summary
No data available
There's currently no market capitalization, revenue or net income data to show.
Valuation ratios

Growth and Profitability

Company’s recent performance and margins

Dividends

Dividend yield, history and sustainability

No dividends
NSTM has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company